{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:07:04Z","timestamp":1771063624128,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05393-x","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:42:35Z","timestamp":1758649355000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial abnormalities in nondiabetic and nonhypertensive glomerular diseases: a comprehensive review"],"prefix":"10.1007","volume":"481","author":[{"given":"Baris","family":"Afsar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rengin","family":"Elsurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista L.","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"5393_CR1","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/s0140-6736(22)00461-5","volume":"399","author":"S Sethi","year":"2022","unstructured":"Sethi S, De Vriese AS, Fervenza FC (2022) Acute glomerulonephritis. Lancet 399:1646\u20131663. https:\/\/doi.org\/10.1016\/s0140-6736(22)00461-5","journal-title":"Lancet"},{"key":"5393_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ki.2014.49","volume":"86","author":"WG Couser","year":"2014","unstructured":"Couser WG, Johnson RJ (2014) The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int 86:905\u2013914. https:\/\/doi.org\/10.1038\/ki.2014.49","journal-title":"Kidney Int"},{"key":"5393_CR3","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/j.ajkd.2021.07.019","volume":"79","author":"S Kant","year":"2022","unstructured":"Kant S, Kronbichler A, Sharma P, Geetha D (2022) Advances in understanding of pathogenesis and treatment of immune-mediated kidney disease: a review. Am J Kidney Dis 79:582\u2013600. https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.019","journal-title":"Am J Kidney Dis"},{"key":"5393_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31110","author":"SM Hejazian","year":"2023","unstructured":"Hejazian SM, Ardalan M, Hosseiniyan Khatibi SM, Rahbar Saadat Y, Barzegari A, Gueguen V, Meddahi-Pell\u00e9 A, Anagnostou F, Zununi Vahed S, Pavon-Djavid G (2023) Biofactors regulating mitochondrial function and dynamics in podocytes and podocytopathies. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.31110","journal-title":"J Cell Physiol"},{"key":"5393_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC (2018) The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol 20:745\u2013754. https:\/\/doi.org\/10.1038\/s41556-018-0124-1","journal-title":"Nat Cell Biol"},{"key":"5393_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/13779","volume":"23","author":"RM Andrews","year":"1999","unstructured":"Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147. https:\/\/doi.org\/10.1038\/13779","journal-title":"Nat Genet"},{"key":"5393_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s1474-4422(21)00098-3","volume":"20","author":"YS Ng","year":"2021","unstructured":"Ng YS, Bindoff LA, Gorman GS, Klopstock T, Kornblum C, Mancuso M, McFarland R, Sue CM, Suomalainen A, Taylor RW, Thorburn DR, Turnbull DM (2021) Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol 20:573\u2013584. https:\/\/doi.org\/10.1016\/s1474-4422(21)00098-3","journal-title":"Lancet Neurol"},{"key":"5393_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y Zong","year":"2024","unstructured":"Zong Y, Li H, Liao P, Chen L, Pan Y, Zheng Y, Zhang C, Liu D, Zheng M, Gao J (2024) Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct Target Ther 9:124. https:\/\/doi.org\/10.1038\/s41392-024-01839-8","journal-title":"Signal Transduct Target Ther"},{"key":"5393_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR, Zeviani M, Turnbull DM (2016) Mitochondrial diseases. Nat Rev Dis Primers 2:16080. https:\/\/doi.org\/10.1038\/nrdp.2016.80","journal-title":"Nat Rev Dis Primers"},{"key":"5393_CR10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/ki.1997.140","volume":"51","author":"P Niaudet","year":"1997","unstructured":"Niaudet P, Rotig A (1997) The kidney in mitochondrial cytopathies. Kidney Int 51:1000\u20131007. https:\/\/doi.org\/10.1038\/ki.1997.140","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"5393_CR11","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.nephro.2017.01.014","volume":"13","author":"F Emma","year":"2017","unstructured":"Emma F, Salviati L (2017) Mitochondrial cytopathies and the kidney. Nephrol Ther 13(Suppl 1):S23-s28. https:\/\/doi.org\/10.1016\/j.nephro.2017.01.014","journal-title":"Nephrol Ther"},{"key":"5393_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1124\/pharmrev.122.000560","volume":"75","author":"KH Cleveland","year":"2023","unstructured":"Cleveland KH, Schnellmann RG (2023) Pharmacological targeting of mitochondria in diabetic kidney disease. Pharmacol Rev 75:250\u2013262. https:\/\/doi.org\/10.1124\/pharmrev.122.000560","journal-title":"Pharmacol Rev"},{"key":"5393_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11906-018-0889-4","volume":"20","author":"A Eirin","year":"2018","unstructured":"Eirin A, Lerman A, Lerman LO (2018) Enhancing mitochondrial health to treat hypertension. Curr Hypertens Rep 20:89. https:\/\/doi.org\/10.1007\/s11906-018-0889-4","journal-title":"Curr Hypertens Rep"},{"key":"5393_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-1016-x","volume":"22","author":"Z Wang","year":"2020","unstructured":"Wang Z, do Carmo JM, da Silva AA, Fu Y, Hall JE (2020) Mechanisms of synergistic interactions of diabetes and hypertension in chronic kidney disease: role of mitochondrial dysfunction and ER stress. Curr Hypertens Rep 22:15. https:\/\/doi.org\/10.1007\/s11906-020-1016-x","journal-title":"Curr Hypertens Rep"},{"key":"5393_CR15","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10157-017-1449-y","volume":"22","author":"Y Harita","year":"2018","unstructured":"Harita Y (2018) Application of next-generation sequencing technology to diagnosis and treatment of focal segmental glomerulosclerosis. Clin Exp Nephrol 22:491\u2013500. https:\/\/doi.org\/10.1007\/s10157-017-1449-y","journal-title":"Clin Exp Nephrol"},{"key":"5393_CR16","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1681\/asn.2013111202","volume":"26","author":"T Kawakami","year":"2015","unstructured":"Kawakami T, Gomez IG, Ren S, Hudkins K, Roach A, Alpers CE, Shankland SJ, D\u2019Agati VD, Duffield JS (2015) Deficient autophagy results in mitochondrial dysfunction and FSGS. J Am Soc Nephrol 26:1040\u20131052. https:\/\/doi.org\/10.1681\/asn.2013111202","journal-title":"J Am Soc Nephrol"},{"key":"5393_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes JM, Thorburn DR (2018) Mitochondrial dysfunction in diabetic kidney disease. Nat Rev Nephrol 14:291\u2013312. https:\/\/doi.org\/10.1038\/nrneph.2018.9","journal-title":"Nat Rev Nephrol"},{"key":"5393_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162481","author":"N Flemming","year":"2022","unstructured":"Flemming N, Pernoud L, Forbes J, Gallo L (2022) Mitochondrial dysfunction in individuals with diabetic kidney disease: a systematic review. Cells. https:\/\/doi.org\/10.3390\/cells11162481","journal-title":"Cells"},{"key":"5393_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1111\/j.1523-1755.2000.00356.x","volume":"58","author":"LM Doleris","year":"2000","unstructured":"Doleris LM, Hill GS, Chedin P, Nochy D, Bellanne-Chantelot C, Hanslik T, Bedrossian J, Caillat-Zucman S, Cahen-Varsaux J, Bariety J (2000) Focal segmental glomerulosclerosis associated with mitochondrial cytopathy. Kidney Int 58:1851\u20131858. https:\/\/doi.org\/10.1111\/j.1523-1755.2000.00356.x","journal-title":"Kidney Int"},{"key":"5393_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1046\/j.1523-1755.2001.0590041236.x","volume":"59","author":"O Hotta","year":"2001","unstructured":"Hotta O, Inoue CN, Miyabayashi S, Furuta T, Takeuchi A, Taguma Y (2001) Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 59:1236\u20131243. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.0590041236.x","journal-title":"Kidney Int"},{"key":"5393_CR21","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1097\/01.asn.0000019772.17954.f8","volume":"13","author":"K Yamagata","year":"2002","unstructured":"Yamagata K, Muro K, Usui J, Hagiwara M, Kai H, Arakawa Y, Shimizu Y, Tomida C, Hirayama K, Kobayashi M, Koyama A (2002) Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions. J Am Soc Nephrol 13:1816\u20131823. https:\/\/doi.org\/10.1097\/01.asn.0000019772.17954.f8","journal-title":"J Am Soc Nephrol"},{"key":"5393_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/PAS.0b013e3181cb4ed3","volume":"34","author":"A Kobayashi","year":"2010","unstructured":"Kobayashi A, Goto Y, Nagata M, Yamaguchi Y (2010) Granular swollen epithelial cells: a histologic and diagnostic marker for mitochondrial nephropathy. Am J Surg Pathol 34:262\u2013270. https:\/\/doi.org\/10.1097\/PAS.0b013e3181cb4ed3","journal-title":"Am J Surg Pathol"},{"key":"5393_CR23","doi-asserted-by":"publisher","first-page":"F1228","DOI":"10.1152\/ajprenal.00143.2013","volume":"305","author":"DL Gasser","year":"2013","unstructured":"Gasser DL, Winkler CA, Peng M, An P, McKenzie LM, Kirk GD, Shi Y, Xie LX, Marbois BN, Clarke CF, Kopp JB (2013) Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and independently, with a decreased content of coenzyme Q10. Am J Physiol Renal Physiol 305:F1228\u2013F1238. https:\/\/doi.org\/10.1152\/ajprenal.00143.2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"5393_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.kint.2021.10.041","volume":"102","author":"MT McNulty","year":"2022","unstructured":"McNulty MT, Fermin D, Eichinger F, Jang D, Kretzler M, Burtt NP, Pollak MR, Flannick J, Weins A, Friedman DJ, Sampson MG (2022) A glomerular transcriptomic landscape of apolipoprotein L1 in Black patients with focal segmental glomerulosclerosis. Kidney Int 102:136\u2013148. https:\/\/doi.org\/10.1016\/j.kint.2021.10.041","journal-title":"Kidney Int"},{"key":"5393_CR25","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/sj.ki.5000207","volume":"69","author":"M Hagiwara","year":"2006","unstructured":"Hagiwara M, Yamagata K, Capaldi RA, Koyama A (2006) Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis. Kidney Int 69:1146\u20131152. https:\/\/doi.org\/10.1038\/sj.ki.5000207","journal-title":"Kidney Int"},{"key":"5393_CR26","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1172\/jci71195","volume":"124","author":"I Daehn","year":"2014","unstructured":"Daehn I, Casalena G, Zhang T, Shi S, Fenninger F, Barasch N, Yu L, D\u2019Agati V, Schlondorff D, Kriz W, Haraldsson B, Bottinger EP (2014) Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest 124:1608\u20131621. https:\/\/doi.org\/10.1172\/jci71195","journal-title":"J Clin Invest"},{"key":"5393_CR27","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.ajpath.2018.08.018","volume":"188","author":"JH Baek","year":"2018","unstructured":"Baek JH, Gomez IG, Wada Y, Roach A, Mahad D, Duffield JS (2018) Deletion of the mitochondrial complex-IV cofactor heme A: farnesyltransferase causes focal segmental glomerulosclerosis and interferon response. Am J Pathol 188:2745\u20132762. https:\/\/doi.org\/10.1016\/j.ajpath.2018.08.018","journal-title":"Am J Pathol"},{"key":"5393_CR28","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1681\/asn.2020071076","volume":"32","author":"F Barutta","year":"2021","unstructured":"Barutta F, Kimura S, Hase K, Bellini S, Corbetta B, Corbelli A, Fiordaliso F, Barreca A, Papotti MG, Ghiggeri GM, Salvidio G, Roccatello D, Audrito V, Deaglio S, Gambino R, Bruno S, Camussi G, Martini M, Hirsch E, Durazzo M, Ohno H, Gruden G (2021) Protective role of the M-sec-tunneling nanotube system in podocytes. J Am Soc Nephrol 32:1114\u20131130. https:\/\/doi.org\/10.1681\/asn.2020071076","journal-title":"J Am Soc Nephrol"},{"key":"5393_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/hmg\/ddab022","volume":"30","author":"M Ge","year":"2021","unstructured":"Ge M, Molina J, Ducasa GM, Mallela SK, Varona Santos J, Mitrofanova A, Kim JJ, Liu X, Sloan A, Mendez AJ, Banerjee S, Liu S, Szeto HH, Shin MK, Hoek M, Kopp JB, Fontanesi F, Merscher S, Fornoni A (2021) APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis. Hum Mol Genet 30:182\u2013197. https:\/\/doi.org\/10.1093\/hmg\/ddab022","journal-title":"Hum Mol Genet"},{"key":"5393_CR30","doi-asserted-by":"publisher","first-page":"16068","DOI":"10.1038\/s41598-019-52535-5","volume":"9","author":"BC Yu","year":"2019","unstructured":"Yu BC, Cho NJ, Park S, Kim H, Choi SJ, Kim JK, Hwang SD, Gil HW, Lee EY, Jeon JS, Noh H, Han DC, Kim YH, Jin SY, Park MY, Kwon SH (2019) Iga nephropathy is associated with elevated urinary mitochondrial DNA copy numbers. Sci Rep 9:16068. https:\/\/doi.org\/10.1038\/s41598-019-52535-5","journal-title":"Sci Rep"},{"key":"5393_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s40001-023-01107-5","volume":"28","author":"X Tang","year":"2023","unstructured":"Tang X, Yuan Y, Liang X, Jiang X (2023) Mitofusin2 expression is associated with podocyte injury in IgA nephropathy. Eur J Med Res 28:142. https:\/\/doi.org\/10.1186\/s40001-023-01107-5","journal-title":"Eur J Med Res"},{"key":"5393_CR32","doi-asserted-by":"publisher","first-page":"2182133","DOI":"10.1080\/0886022x.2023.2182133","volume":"45","author":"J Liu","year":"2023","unstructured":"Liu J, Wang R, Luo N, Li Z, Mao H, Zhou Y (2023) Mitochondrial DNA copy number in peripheral blood of IgA nephropathy: a cross-sectional study. Ren Fail 45:2182133. https:\/\/doi.org\/10.1080\/0886022x.2023.2182133","journal-title":"Ren Fail"},{"key":"5393_CR33","doi-asserted-by":"publisher","first-page":"5438","DOI":"10.7150\/ijbs.74675","volume":"18","author":"J Wu","year":"2022","unstructured":"Wu J, Shao X, Shen J, Lin Q, Zhu X, Li S, Li J, Zhou W, Qi C, Ni Z (2022) Downregulation of PPAR\u03b1 mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells. Int J Biol Sci 18:5438\u20135458. https:\/\/doi.org\/10.7150\/ijbs.74675","journal-title":"Int J Biol Sci"},{"key":"5393_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.prostaglandins.2014.06.001","volume":"112","author":"Y Goto","year":"2014","unstructured":"Goto Y, Yamaguchi S, Tamura M, Mochizuki H, Kurumatani H, Okano K, Miyamoto M (2014) A prostacyclin analog prevents the regression of renal microvascular network by inhibiting mitochondria-dependent apoptosis in the kidney of rat progressive glomerulonephritis. Prostaglandins Other Lipid Mediat 112:16\u201326. https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.06.001","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"5393_CR35","doi-asserted-by":"publisher","first-page":"14468","DOI":"10.1074\/jbc.M115.696781","volume":"291","author":"H Elimam","year":"2016","unstructured":"Elimam H, Papillon J, Kaufman DR, Guillemette J, Aoudjit L, Gross RW, Takano T, Cybulsky AV (2016) Genetic ablation of calcium-independent phospholipase A2\u03b3 induces glomerular injury in mice. J Biol Chem 291:14468\u201314482. https:\/\/doi.org\/10.1074\/jbc.M115.696781","journal-title":"J Biol Chem"},{"key":"5393_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2769487","volume":"2022","author":"J Luan","year":"2022","unstructured":"Luan J, Jiao C, Ma C, Zhang Y, Hao X, Zhou G, Fu J, Qiu X, Li H, Yang W, Illei GG, Kopp JB, Pi J, Zhou H (2022) circMTND5 participates in renal mitochondrial injury and fibrosis by sponging MIR6812 in lupus nephritis. Oxid Med Cell Longev 2022:2769487. https:\/\/doi.org\/10.1155\/2022\/2769487","journal-title":"Oxid Med Cell Longev"},{"key":"5393_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/08916934.2018.1442828","volume":"51","author":"M Dos Santos","year":"2018","unstructured":"Dos Santos M, Poletti PT, Favero G, Stacchiotti A, Bonomini F, Montanari CC, Bona SR, Marroni NP, Rezzani R, Veronese FV (2018) Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis. Autoimmunity 51:69\u201380. https:\/\/doi.org\/10.1080\/08916934.2018.1442828","journal-title":"Autoimmunity"},{"key":"5393_CR38","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41419-022-04737-5","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang H, Lv D, Jiang S, Hou Q, Zhang L, Li S, Zhu X, Xu X, Wen J, Zeng C, Zhang M, Yang F, Chen Z, Zheng C, Li J, Zen K, Liu Z, Li L (2022) Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction. Cell Death Dis 13:281. https:\/\/doi.org\/10.1038\/s41419-022-04737-5","journal-title":"Cell Death Dis"},{"key":"5393_CR39","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1159\/000496006","volume":"43","author":"QJ Wei","year":"2018","unstructured":"Wei QJ, Xu H, Guan N, Ren YL, Liu XY, Wu GH, Zhu SN (2018) Overproduction of mitochondrial fission proteins in membranous nephropathy in children. Kidney Blood Press Res 43:1927\u20131934. https:\/\/doi.org\/10.1159\/000496006","journal-title":"Kidney Blood Press Res"},{"key":"5393_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00415-003-0978-3","volume":"250","author":"J Schmiedel","year":"2003","unstructured":"Schmiedel J, Jackson S, Sch\u00e4fer J, Reichmann H (2003) Mitochondrial cytopathies. J Neurol 250:267\u2013277. https:\/\/doi.org\/10.1007\/s00415-003-0978-3","journal-title":"J Neurol"},{"key":"5393_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0196-7","volume":"6","author":"JB Kopp","year":"2020","unstructured":"Kopp JB, Anders HJ, Susztak K, Podest\u00e0 MA, Remuzzi G, Hildebrandt F, Romagnani P (2020) Podocytopathies. Nat Rev Dis Primers 6:68. https:\/\/doi.org\/10.1038\/s41572-020-0196-7","journal-title":"Nat Rev Dis Primers"},{"key":"5393_CR42","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1369\/0022155419850170","volume":"67","author":"J Zhong","year":"2019","unstructured":"Zhong J, Whitman JB, Yang HC, Fogo AB (2019) Mechanisms of scarring in focal segmental glomerulosclerosis. J Histochem Cytochem 67:623\u2013632. https:\/\/doi.org\/10.1369\/0022155419850170","journal-title":"J Histochem Cytochem"},{"key":"5393_CR43","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1053\/j.ajkd.2016.06.027","volume":"68","author":"M Rudnicki","year":"2016","unstructured":"Rudnicki M, Mayr JA, Zschocke J, Antretter H, Regele H, Feichtinger RG, Windpessl M, Mayer G, P\u00f6lzl G (2016) MELAS syndrome and kidney disease without Fanconi syndrome or proteinuria: a case report. Am J Kidney Dis 68:949\u2013953. https:\/\/doi.org\/10.1053\/j.ajkd.2016.06.027","journal-title":"Am J Kidney Dis"},{"key":"5393_CR44","first-page":"347","volume":"46","author":"H Mochizuki","year":"1996","unstructured":"Mochizuki H, Joh K, Kawame H, Imadachi A, Nozaki H, Ohashi T, Usui N, Eto Y, Kanetsuna Y, Aizawa S (1996) Mitochondrial encephalomyopathies preceded by de-Toni-Debr\u00e9-Fanconi syndrome or focal segmental glomerulosclerosis. Clin Nephrol 46:347\u2013352","journal-title":"Clin Nephrol"},{"key":"5393_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.mito.2012.10.011","volume":"13","author":"AN Malik","year":"2013","unstructured":"Malik AN, Czajka A (2013) Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion 13:481\u2013492. https:\/\/doi.org\/10.1016\/j.mito.2012.10.011","journal-title":"Mitochondrion"},{"key":"5393_CR46","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1074\/jbc.RA118.005659","volume":"294","author":"R Pergu","year":"2019","unstructured":"Pergu R, Dagar S, Kumar H, Kumar R, Bhattacharya J, Mylavarapu SVS (2019) The chaperone ERp29 is required for tunneling nanotube formation by stabilizing MSec. J Biol Chem 294:7177\u20137193. https:\/\/doi.org\/10.1074\/jbc.RA118.005659","journal-title":"J Biol Chem"},{"key":"5393_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ (2016) IgA nephropathy. Nat Rev Dis Primers 2:16001. https:\/\/doi.org\/10.1038\/nrdp.2016.1","journal-title":"Nat Rev Dis Primers"},{"key":"5393_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020570","author":"C Tanriover","year":"2023","unstructured":"Tanriover C, Copur S, Ucku D, Cakir AB, Hasbal NB, Soler MJ, Kanbay M (2023) The mitochondrion: a promising target for kidney disease. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15020570","journal-title":"Pharmaceutics"},{"key":"5393_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-015-0044-z","volume":"12","author":"S Granata","year":"2015","unstructured":"Granata S, Dalla Gassa A, Tomei P, Lupo A, Zaza G (2015) Mitochondria: a new therapeutic target in chronic kidney disease. Nutr Metab (Lond) 12:49. https:\/\/doi.org\/10.1186\/s12986-015-0044-z","journal-title":"Nutr Metab (Lond)"},{"key":"5393_CR50","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/nejm199509073331007","volume":"333","author":"DR Johns","year":"1995","unstructured":"Johns DR (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 333:638\u2013644. https:\/\/doi.org\/10.1056\/nejm199509073331007","journal-title":"N Engl J Med"},{"key":"5393_CR51","doi-asserted-by":"publisher","first-page":"10614","DOI":"10.1073\/pnas.88.23.10614","volume":"88","author":"J Hayashi","year":"1991","unstructured":"Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I (1991) Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A 88:10614\u201310618. https:\/\/doi.org\/10.1073\/pnas.88.23.10614","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5393_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-199801000-00006","volume":"77","author":"M Zeviani","year":"1998","unstructured":"Zeviani M, Tiranti V, Piantadosi C (1998) Mitochondrial disorders. Medicine (Baltimore) 77:59\u201372. https:\/\/doi.org\/10.1097\/00005792-199801000-00006","journal-title":"Medicine (Baltimore)"},{"key":"5393_CR53","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/oxfordjournals.ndt.a027391","volume":"11","author":"JP Gr\u00fcnfeld","year":"1996","unstructured":"Gr\u00fcnfeld JP, Niaudet P, R\u00f6tig A (1996) Renal involvement in mitochondrial cytopathies. Nephrol Dial Transplant 11:760\u2013761. https:\/\/doi.org\/10.1093\/oxfordjournals.ndt.a027391","journal-title":"Nephrol Dial Transplant"},{"key":"5393_CR54","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/ndt\/gfh546","volume":"20","author":"MM L\u00f6wik","year":"2005","unstructured":"L\u00f6wik MM, Hol FA, Steenbergen EJ, Wetzels JF, van den Heuvel LP (2005) Mitochondrial tRNALeu(UUR) mutation in a patient with steroid-resistant nephrotic syndrome and focal segmental glomerulosclerosis. Nephrol Dial Transpl 20:336\u2013341. https:\/\/doi.org\/10.1093\/ndt\/gfh546","journal-title":"Nephrol Dial Transpl"},{"key":"5393_CR55","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1172\/jci69000","volume":"123","author":"S Ashraf","year":"2013","unstructured":"Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschk\u00e9 P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, B\u00f6ckenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F (2013) ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest 123:5179\u20135189. https:\/\/doi.org\/10.1172\/jci69000","journal-title":"J Clin Invest"},{"key":"5393_CR56","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.kint.2022.04.029","volume":"102","author":"S Drovandi","year":"2022","unstructured":"Drovandi S, Lipska-Zi\u0119tkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schreuder MF, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Liu C, Sun S, Deng F, Wang X, Clav\u00e9 S, Sta\u0144czyk M, Ba\u0142asz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G, Schaefer F (2022) Oral coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary coenzyme Q10 deficiency. Kidney Int 102:604\u2013612. https:\/\/doi.org\/10.1016\/j.kint.2022.04.029","journal-title":"Kidney Int"},{"key":"5393_CR57","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s00467-017-3634-3","volume":"32","author":"M Atmaca","year":"2017","unstructured":"Atmaca M, Gulhan B, Korkmaz E, Inozu M, Soylemezoglu O, Candan C, Bayaz\u0131t AK, Elmac\u0131 AM, Parmaksiz G, Duzova A, Besbas N, Topaloglu R, Ozaltin F (2017) Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. Pediatr Nephrol 32:1369\u20131375. https:\/\/doi.org\/10.1007\/s00467-017-3634-3","journal-title":"Pediatr Nephrol"},{"key":"5393_CR58","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/art.41128","volume":"72","author":"LP Blanco","year":"2020","unstructured":"Blanco LP, Pedersen HL, Wang X, Lightfoot YL, Seto N, Carmona-Rivera C, Yu ZX, Hoffmann V, Yuen PST, Kaplan MJ (2020) Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone. Arthritis Rheumatol 72:454\u2013464. https:\/\/doi.org\/10.1002\/art.41128","journal-title":"Arthritis Rheumatol"},{"key":"5393_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0169-409x(99)00069-1","volume":"41","author":"MP Murphy","year":"2000","unstructured":"Murphy MP, Smith RA (2000) Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 41:235\u2013250. https:\/\/doi.org\/10.1016\/s0169-409x(99)00069-1","journal-title":"Adv Drug Deliv Rev"},{"key":"5393_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1742-7843.2011.00785.x","volume":"110","author":"AC Montezano","year":"2012","unstructured":"Montezano AC, Touyz RM (2012) Reactive oxygen species and endothelial function\u2013role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 110:87\u201394. https:\/\/doi.org\/10.1111\/j.1742-7843.2011.00785.x","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05393-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05393-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:25:54Z","timestamp":1771061154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05393-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["5393"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05393-x","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}